Hospital Market in India 2014

  • Report Code : NSC250670
  • Pages : 57
  • Published On : Mar 2012
  • Industry : Healthcare and Pharmaceuticals
  • Format :

Choose License Type

Single User License: US$ 950
Multi User License: US$ 0
The Hospital Market in India is a very potential market that has incessant possibility of growth due to continuous demand for quality healthcare service. Thus, there is tremendous growth prospect of the hospital market. India is reeling under the lack of adequate number of hospital beds in comparison to the demand it faces and the poor quality of public hospitals of the country.

The report begins with the introduction section that deals with the types and specifications of the hospitals followed by the standard healthcare infrastructure prevalent in India. The section is then followed by the Market Overview of the Hospital Market that has highlighted the current market scenario with the expected market size till the year 2016.

The report provides the driving factors that are encouraging the hospital market among which the shortage in adequate number of hospital beds in the country finds the most prominent position. The ever growing healthcare industry, growing affordability among people for better hospital care, growing medical tourism industry, increasing lifestyle diseases, changing demographic structure and growth in health insurance market happen to be the other significant reasons for driving ahead the hospital market.. The drivers have been analyzed with suitable examples. The key challenges include shortage of qualified medical professionals, lack of investment in IT infrastructure by hospitals and lack of foreign direct investment the country faces in the hospitals and diagnostic centres.

The next section deals with the role of government in helping to make the country's healthcare scenario better. The direct and indirect measures, financial incentives that help in growth of the private sector and public sector's plans of establishing new hospitals aimed for the underprivileged.

The following section deals with the trends prevalent in the hospital market. It includes emergence of Secondary Care Hospitals, growing interest of the foreign players to set up hospitals in India, joint ventures undertaken by public and private for improvement in healthcare standard of the country, funding of hospitals by Private Equity firms and the increasing prevalence of mobile hospitals to provide facilities to the under privileged, domestic hospitals offshore expansion along with telemedicine and health city emergence in hospital market.

The competition section gives overview of hospitals in the country that have grown over time segmented on the basis of region. It is then followed by some hospitals that have or will soon commence operation in 2012-13. The competition section is further provides an overview of the competitive landscape in the market. A Porters Five Forces Analysis has been incorporated for a brief but effective understanding of the market scenario. The section includes elaborate profile of the major players in the market incorporating the general company information, product lines and segmentation, the financials that is well analysed through key ratios thereby depicting the financial position of the company in terms of its revenue earning and profitability, business highlights and recent developments of the respective company for the major players in the market.

The strategic recommendations section focuses on some effective strategic decisions which can be taken up by players to increase their market shares. The recommendations provided at the end of the report can prove to be useful for the existing as well as potential entrants into the market.
Page 1: Executive summary
Introduction
Page 2: Classification of type of hospitals
Market Overview
Page3: Indian healthcare infrastructure
Page 4: Indian Private Hospital Market - Overview, Size & Growth (Value: 2010-16e)
Drivers & Challenges
Page 5: Summary
Page 6-12: Drivers
Page13-15: Challenges
Government Initiatives
Page 16: Summary
Page 17-19: Government role in hospital market
Trends
Page 20: Summary
Page 21-28: Recent trends
Competition
Page 29-32: Region wise major hospital profiles
Page 33: Hospitals commissioned for 2012-13
Page 34: Market Competition - Porter's Five Forces Analysis
Page 35: Summary: Major public players
Page 36-42: Major public players
Apollo Hospitals Enterprise Ltd.
Fortis Healthcare (India) Ltd.
Page 43: Summary: Major private players
Page 44-55: Major private players
Max Healthcare Institute Ltd.
Wockhardt Hospitals Ltd.
Columbia Asia Hospital Private Ltd.
Narayana Hrudayalaya Hospitals
Strategic recommendation
Page 56: Strategic Recommendations
Appendix
Page 57: Appendix

Hospital Supplies and Consumable Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Hospital Supplies and Consumable Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...

Hospital Treatment Fee Evaluation Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Hospital Treatment Fee Evaluation Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...

Modular Hospital Field Solutions Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Modular Hospital Field Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, ma...

Hospital Location Management Software Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Hospital Location Management Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...

Asia Pacific Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Idiopathic Pulmonary Fibrosis (IPF) Market is expected to witness substantial growth from 2024 to 2034, driven by the rising prevalence of IPF, advancements in drug development, and an increasing focus on early diagnosis and treatment. The market is proj...

Europe Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Idiopathic Pulmonary Fibrosis (IPF) Market is expected to witness significant growth between 2024 and 2034, driven by the increasing prevalence of IPF, advancements in drug development, and improved diagnostic methods. The market is projected to reach USD XX.X...

North America Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The North America Idiopathic Pulmonary Fibrosis (IPF) Market is projected to experience robust growth from 2024 to 2034, driven by advancements in therapeutic options, increasing prevalence of IPF, and a growing emphasis on early diagnosis and treatment. The market size ...

Global Idiopathic Pulmonary Fibrosis Market Size, Share, Trends & Analysis by Drug Class (MAPK Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors), by Route of Administration (Oral, Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Global Idiopathic Pulmonary Fibrosis (IPF) Market is poised to experience significant growth between 2024 and 2034, driven by advancements in drug development, increasing prevalence of IPF, and heightened awareness about the disease. Valued at USD XX.XX billion in 20...

Asia Pacific Neurofibromatosis Treatment Market Size, Share, Trends & Analysis by Disease Type (Neurofibromatosis 1 (NF1), Neurofibromatosis 2 (NF2), Schwannomatosis), by Treatment (Medications, Surgery, Radiation Therapy, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Neurofibromatosis Treatment Market is anticipated to witness substantial growth from 2024 to 2034, driven by increasing awareness and diagnosis of neurofibromatosis (NF), advancements in treatment options, and a growing patient population. The market is ...

Europe Neurofibromatosis Treatment Market Size, Share, Trends & Analysis by Disease Type (Neurofibromatosis 1 (NF1), Neurofibromatosis 2 (NF2), Schwannomatosis), by Treatment (Medications, Surgery, Radiation Therapy, Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Neurofibromatosis Treatment Market is projected to experience substantial growth from 2024 to 2034, driven by advancements in medical treatments, increasing prevalence of neurofibromatosis disorders, and rising awareness about these conditions. The market is e...